Delivery Order SPE2DB20D3103-SPE2DB25FP1P6
Award Date 6/12/25
Potential Completion Date 6/13/25
Potential Value $39K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,620.28 by the Defense Logistics Agency's Medical Supply Chain for the delivery of MENVEO VACCINE VL 5S, a meningococcal vaccine product. The contract, awarded on September 12, 2025, utilizes firm fixed pricing with an ultimate completion date of October 9, 2025. This is a competitive award with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. This firm fixed price delivery order, valued at $3,789.19, represents a competitively awarded contract with no set-aside designation and is scheduled for completion by July 31, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $34,059.20 on August 29, 2025, for supply of Menveo A-C-Y-W Kit (2 Vials), a meningococcal vaccine product. This competitively awarded, firm fixed-price delivery order is funded by the Defense Logistics Agency Medical Supply Chain, a defense agency component, with an ultimate completion date of September 2, 2025. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $20,375.92 for the Menveo vaccine (5-dose vial) by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of September 17, 2025. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- This delivery order, issued by the Defense Logistics Agency (DLA), awards AmerisourceBergen Drug Corp $1,260.84 for the supply of Menveo vaccine (1 vial, formulation A-C-Y-W-135-DIP, 0.5ml) with completion targeted for June 30, 2025. The award utilizes firm fixed pricing under a non-set-aside, competitive procurement process. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary distribution operations. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at approximately $45K on July 23, 2025, for the supply of Menveo vaccine (5-dose vials). This competitively awarded, firm fixed-price delivery order is expected to be completed by July 24, 2025, and will be performed at the contractor's Conshohocken facility. The award was funded by the Defense Logistics Agency's Medical Supply Chain, which procures...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,127.55 to AmerisourceBergen Drug Corp for the supply of Menveo 1 Vial-A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine product. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure. Performance is scheduled for completion by September 22, 2025, with the place of performance located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a $175,856.28 firm fixed price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Menveo 1 Vial A-C-Y-W-135-DIP 0.5ML, a meningococcal vaccine. The contract is scheduled for completion by June 23, 2025, and performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a non-competitive award issued under an existing indefinite delivery contract vehicle, reflecting...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a $24,637.20 delivery order by the Defense Logistics Agency (DLA) for MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a meningococcal conjugate vaccine. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 22, 2025, and will be performed at the company's Conshohocken location. The award represents a child delivery order under AmerisourceBergen Drug Corp's larger prime...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $13,616.96 firm fixed-price delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Menveo A-C-Y-W vaccine kits (2 vials). The contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at...